SELAS GRANDE PHARMACIE PRINCIPALE : revenue, balance sheet and financial ratios

SELAS GRANDE PHARMACIE PRINCIPALE is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BORDEAUX (33000), this company of category PME shows in 2023 a revenue of 5.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS GRANDE PHARMACIE PRINCIPALE (SIREN 483161758)
Indicator 2024 2023 2022 2021 2019 2018 2017 2016
Revenue N/C 5 363 491 € 5 376 757 € 5 722 914 € 6 926 959 € N/C 6 486 336 € 6 364 049 €
Net income 39 349 € -119 093 € -706 272 € -33 998 € 167 115 € 119 134 € 84 448 € 256 068 €
EBITDA N/C 298 230 € -96 496 € 144 709 € 372 849 € N/C 371 316 € 464 452 €
Net margin N/C -2.2% -13.1% -0.6% 2.4% N/C 1.3% 4.0%

Revenue and income statement

In 2024, SELAS GRANDE PHARMACIE PRINCIPALE generates positive net income of 39 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 256 k€ -> 39 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

39 349 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -581%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-580.846%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-16.753%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

4.4%

Solvency indicators evolution
SELAS GRANDE PHARMACIE PRINCIPALE

Sector positioning

Debt ratio
-580.85 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of SELAS GRANDE PHARMACIE PR... (-580.85) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-16.75% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELAS GRANDE PHARMACIE PR... (-16.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-49.11 years 2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent

In 2023, the repayment capacity of SELAS GRANDE PHARMACIE PR... (-49.11) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 157.58. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

157.584

Liquidity indicators evolution
SELAS GRANDE PHARMACIE PRINCIPALE

Sector positioning

Liquidity ratio
157.58 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average

In 2024, the liquidity ratio of SELAS GRANDE PHARMACIE PR... (157.58) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
115.39x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent +51 pts over 2 years

In 2023, the interest coverage of SELAS GRANDE PHARMACIE PR... (115.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS GRANDE PHARMACIE PRINCIPALE

Positioning of SELAS GRANDE PHARMACIE PRINCIPALE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS GRANDE PHARMACIE PRINCIPALE is estimated at 549 341 € (range 382 552€ - 821 845€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
382k€ 549k€ 821k€
549 341 € Range: 382 552€ - 821 845€
NAF 5 année 2024

Valuation method used

Net Income Multiple
39 349 € × 14.0x = 549 341 €
Range: 382 552€ - 821 846€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS GRANDE PHARMACIE PRINCIPALE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS GRANDE PHARMACIE PRINCIPALE

What is the revenue of SELAS GRANDE PHARMACIE PRINCIPALE ?

The revenue of SELAS GRANDE PHARMACIE PRINCIPALE in 2023 is 5.4 M€.

Is SELAS GRANDE PHARMACIE PRINCIPALE profitable?

Yes, SELAS GRANDE PHARMACIE PRINCIPALE generated a net profit of 39 k€ in 2024.

Where is the headquarters of SELAS GRANDE PHARMACIE PRINCIPALE ?

The headquarters of SELAS GRANDE PHARMACIE PRINCIPALE is located in BORDEAUX (33000), in the department Gironde.

Where to find the tax return of SELAS GRANDE PHARMACIE PRINCIPALE ?

The tax return of SELAS GRANDE PHARMACIE PRINCIPALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS GRANDE PHARMACIE PRINCIPALE operate?

SELAS GRANDE PHARMACIE PRINCIPALE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.